Active Stocks
Thu Feb 13 2025 15:56:24
  1. Tata Steel share price
  2. 136.20 2.99%
  1. Tata Motors share price
  2. 683.65 -0.11%
  1. Wipro share price
  2. 308.50 -0.55%
  1. State Bank Of India share price
  2. 727.30 -0.81%
  1. NTPC share price
  2. 306.95 0.23%
Business News/Market/Market Stats/    HDFC Pharma and Healthcare Fund Regular Growth

HDFC Pharma and Healthcare Fund Regular Growth

+
  • Equity
  • Sector - Healthcare
  • Rating N.A.
  • Plan
15.52 -0.07 (-0.44%) NAV as on 12 Feb, 2025
  • 5D
  • 1M
  • 6M
  • 1Y
  • 5Y
  • MAX

Key Metrics

  • AUM (in Cr)1577.12
  • CAGR 25.99%
  • Exit Load1.00%
  • Expense ratio2.14%
  • CategoryEquity
  • Min Investment100
  • Min SIP100
  • Launch Date2023-10-04

Morning Star Rating N.A.

Medium
Risk
Exceptional
Return

Asset Allocation

Holdings As On - 13 February 2025

  • Name
  • Value (Cr)
  • Holding %
  • Treps - Tri-Party Repo
  • 54.00
  • 3.42%
View More

Risk & Volitility

  • Alpha 0.00%
  • Beta 0.00
  • Sharpe Ratio0.00
  • Std Deviation 0.00%
  • Tracking Error 0.00%

About Fund

To provide long-term capital appreciation by investing predominantly in equity and equity related securities of Pharma and healthcare companies. There is no assurance that the investment objective of the Scheme will be realized.

 

The HDFC Pharma and Healthcare Fund Regular Growth has an AUM of 1577.12 crores & has delivered CAGR of 0.00% in the last 5 years. The fund has an exit load of 1.00% and an expense ratio of 2.14%. The minimum investment in HDFC Pharma and Healthcare Fund Regular Growth is Rs 100 and the minimum SIP is Rs 100.

 

As per morningstar the risk & return rating of the fund are Medium & Exceptional respectively.

 

The top holdings of the fund include Sun Pharmaceutical Industries, Cipla, Divis Laboratories & Lupin.

 

The major sectors where the fund is invested are Biotechnology & Drugs, Healthcare Facilities, Major Drugs & Chemical Manufacturing.

 

Some of the similar funds are DSP Healthcare Fund Regular Growth, Tata India Pharma & Healthcare Fund Regular Growth, UTI Healthcare Fund Regular Plan Growth, Mirae Asset Healthcare Fund Regular Growth, HDFC Pharma and Healthcare Fund Regular Growth. HDFC Pharma and Healthcare Fund Regular Growth has a sharpe ratio of 0.00 & a standard deviation of 0.00%.

FAQs about HDFC Pharma and Healthcare Fund Regular Growth

According to the morning star rating HDFC Pharma and Healthcare Fund Regular Growth has a Medium risk & Exceptional return.
HDFC Pharma and Healthcare Fund Regular Growth is managed by Dhruv Muchhal,Nikhil Mathur.
The expense ratio of HDFC Pharma and Healthcare Fund Regular Growth is 2.14%.
The 5 year annualized return on HDFC Pharma and Healthcare Fund Regular Growth is 0.00% & it has generated 25.99% in the last 1 year.
The minimum investment in HDFC Pharma and Healthcare Fund Regular Growth is 100 Rs.
HDFC Pharma and Healthcare Fund Regular Growth has an AUM of 1577.12 crores.
Recommended For You